Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
KHTRF
Primary Symbol:
T.GUD
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jun 18, 2024 8:20pm
RE:LATAM #1 pharma growth - 22% yoy compounded growth
This poster has been wrong and lost fortunes on GUD for the past 10 years
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jun 14, 2024 8:51am
LATAM #1 pharma growth - 22% yoy compounded growth
Leading worldwide pharma markets. Reviewed this article from PharmaBoardroom https://pharmaboardroom.com/facts/the-worlds-fastest-growing-pharma-markets-up-to-2027/
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jun 04, 2024 7:09pm
RE:Analyst buys goes to 5 from 4 on stockhouse ?
Big deal, why are you not comenting on the share price sinking like a rock? BTW doe anyone know what happened to Mr Mugsy, I miss Mr Mugsy as I always like to trade short what Mr Mugsy liked.
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jun 03, 2024 1:28pm
Analyst buys goes to 5 from 4 on stockhouse ?
Did anyone else note this change or am I not remebering? i thought there were perpetually 4 buys, 2 holds & 0 sells. & I notice today that there are now 5! are more people noticing?
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on May 24, 2024 6:40am
RE:Trevor Rose's Insights - DON'T BUY
11 years later after GUD did a PP at $10 it has never see $10 again. What else can be said about this MNGT? 100% faillure
(8)
•••
wofats
X
View Profile
View Bullboard History
Post by
wofats
on May 15, 2024 10:33am
Question?
This is the short position on the 29 April .About 3,100,000 shares The stock was at 5.79 on that reporting day. At what point do they have to cover the shorts? What proce increase has to happen before
...more
(1914)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on May 13, 2024 11:04pm
Trevor Rose's Insights - DON'T BUY
DON'T BUY Knight Therapeutics(GUD-T) 13/05/2024 Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research The stock is acting better,
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Comment by
GoldenInvestor
on May 11, 2024 10:31pm
RE:RE:RE:RE:Again? Is it support or faith?
How many shares does he have? What's the value ? How many shares did they have to start? how many shares remain?
(8)
•••
wofats
X
View Profile
View Bullboard History
Comment by
wofats
on May 11, 2024 11:32am
RE:RE:Again? Is it support or faith?
You may be correct iled 2024-05-10 13:32 Tx date 2024-05-09 $GUD Knight Therapeutics Inc. Armoyan, Sime 3 - 10% Security
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on May 10, 2024 10:10am
RE:RE:Sorry...
Yes, although we're getting close to a point where the fund investments can no longer be classified as having done well. It's been several years since they were made, the money will be tied
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on May 10, 2024 8:29am
$120 Million investment in smaller firm by big player
As an eg of opportunities and DEMAND for production. - fr CNBC *** Novavax shares spike 120% on Sanofi deal to commercialize Covid vaccine, develop
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on May 09, 2024 4:16pm
RE:Sorry...
I think the market is more excited about the pipeline. They have succeeded in buildign out their platform and also done a great job with the pipeline. They still had $30M of cash from operations.
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 09, 2024 7:30am
New Press Release - Knight Therapeutics Reports First Quarter 2024 Results
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2024. All currency amounts are in thousands except...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 09, 2024 7:30am
New Press Release - Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an exclusive supply and distribution agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >